
After 28 years across code, product, and operations, the founder of RhythmX AI has arrived at a stubbornly practical thesis: intelligence matters only when it reaches the person who can act on it.
Most clinical AI is trying to write the note. RhythmX AI wants to decide what deserves the doctor's attention next - and its merger with Get Well reveals why distribution may matter as much as the model.
The 130-year medical-technology lineage is no longer selling scanners alone. Its bet is that imaging hardware, diagnostic drugs, cloud software and AI can work as one connected care system - without asking clinicians to become IT departments.